BIA Wants More Brexit Clarity From UK Regulator As Odds Narrow On ‘No-Deal’ Outcome
Executive Summary
The BioIndustry Association is concerned about the lack of clarity on future UK-EU drug regulation after EU heads of state failed to make any tangible progress on Brexit at their much heralded end-of-June summit.